The American Journal of Managed Care2d
Changes in Tumor Size Track Advanced RCC Outcomes, Analyses From CLEAR Show
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Harvard Medical School8d
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
The American Journal of Managed Care8d
Promising Cancer Vaccine Boosts Hope for Stage III and IV Kidney Cancer
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
HealthDay on MSN7d
Therapeutic Vaccine May Fight Advanced Kidney Cancer
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...
Cure Today9d
Circulating Tumor DNA May Have Prognostic Value in Kidney Cancer
Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA. Among patients with metastatic renal cell carcinoma (mRCC), serial ...